Product Information

ETRAVIRINE 200 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $10.7885 per EA under NDC 60219172206. Its NADAC has been published 218 times since Jun 22, 2022.

FDA first approved this application on Jun 14, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ETRAVIRINE 200 MG TABLET

etravirine
$10.7885per EA

Strength

200 mg/1

NDC

60219172206

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ETRAVIRINE

Approval Type

Generic (ANDA)

FDA Application

ANDA214196

FDA Approved

6/14/2021

TE Code

AB

On Market Since

6/14/2021

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for ETRAVIRINE 200 MG TABLET has been published 218 times since Jun 22, 2022, and over the history we have for it it has declined 39.1%. The table below summarizes its recorded NADAC range and movement.

Current price$10.7885 per EA
All-time high$17.7091 (Mar 15, 2023)
All-time low$10.7885 (Aug 19, 2026)
52-week high$11.9268
52-week low$10.7885
Median price$13.2554
Average price$14.1468
Largest weekly change+13.4% (Oct 23, 2024)
Weeks tracked218
Tracking sinceJun 22, 2022

Price History

1W

-4.0%

1M

-4.0%

3M

-4.3%

6M

-7.7%

1Y

-9.5%

3Y

-35.4%

5Y

N/A

All

-39.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ETRAVIRINE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ETRAVIRINE 200 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $10.7885 per EA (NDC 60219172206), effective Aug 19, 2026.

How has the price of ETRAVIRINE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for ETRAVIRINE 200 MG TABLET has declined 39.1%. It has been tracked across 218 weekly CMS publications since Jun 22, 2022.

What are the highest and lowest recorded NADAC prices for ETRAVIRINE 200 MG TABLET?

Since Jun 22, 2022, the NADAC for ETRAVIRINE 200 MG TABLET has ranged from a low of $10.7885 (Aug 19, 2026) to a high of $17.7091 (Mar 15, 2023), with a median of $13.2554 per EA.

Are there cheaper alternatives to ETRAVIRINE 200 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETRAVIRINE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ETRAVIRINE 200 MG TABLET?

ETRAVIRINE 200 MG TABLET (NDC 60219172206) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.